Kolakowska K, Kisluk J, Niklinski J
Int J Mol Sci. 2025; 26(5).
PMID: 40076482
PMC: 11900017.
DOI: 10.3390/ijms26051857.
Lazaridis A, Katifelis H, Kalampokas E, Lambropoulou D, Aravantinos G, Gazouli M
Int J Mol Sci. 2024; 25(21).
PMID: 39519256
PMC: 11546551.
DOI: 10.3390/ijms252111703.
Ren F, Cai X, Yao Y, Fang G
Front Cell Infect Microbiol. 2023; 13:1222265.
PMID: 37731821
PMC: 10507257.
DOI: 10.3389/fcimb.2023.1222265.
Dai G, Sun Y, Wei R, Xi L
Curr Issues Mol Biol. 2023; 45(7):6116-6139.
PMID: 37504302
PMC: 10378008.
DOI: 10.3390/cimb45070386.
Liu W, Ying N, Rao X, Chen X
Curr Issues Mol Biol. 2022; 44(9):3835-3848.
PMID: 36135175
PMC: 9498168.
DOI: 10.3390/cimb44090263.
miR-1908: a microRNA with diverse functions in cancers and non-malignant conditions.
Ghafouri-Fard S, Khoshbakht T, Hussen B, Taheri M, Samsami M
Cancer Cell Int. 2022; 22(1):281.
PMID: 36100870
PMC: 9469614.
DOI: 10.1186/s12935-022-02709-5.
miR-1908 Dysregulation in Human Cancers.
Shen J, Wu Y, Ruan W, Zhu F, Duan S
Front Oncol. 2022; 12:857743.
PMID: 35463352
PMC: 9021824.
DOI: 10.3389/fonc.2022.857743.
Development and Validation of a Novel Histone Acetylation-Related Gene Signature for Predicting the Prognosis of Ovarian Cancer.
Dai Q, Ye Y
Front Cell Dev Biol. 2022; 10:793425.
PMID: 35252174
PMC: 8894724.
DOI: 10.3389/fcell.2022.793425.
Methylation Serves as a Prognostic Biomarker and Associates with Immune Cell Infiltration and Immune Checkpoint Blockade Response in Lower-Grade Glioma.
Noor H, Zaman A, Teo C, Sughrue M
Int J Mol Sci. 2021; 22(22).
PMID: 34830454
PMC: 8625785.
DOI: 10.3390/ijms222212572.
Extracellular Vesicle-Associated miRNAs and Chemoresistance: A Systematic Review.
Campos A, Sharma S, Obermair A, Salomon C
Cancers (Basel). 2021; 13(18).
PMID: 34572835
PMC: 8472653.
DOI: 10.3390/cancers13184608.
SIRT4 and SIRT6 Serve as Novel Prognostic Biomarkers With Competitive Functions in Serous Ovarian Cancer.
Wang H, Li J, Huang R, Fang L, Yu S
Front Genet. 2021; 12:666630.
PMID: 34335684
PMC: 8320514.
DOI: 10.3389/fgene.2021.666630.
Small Non-Coding-RNA in Gynecological Malignancies.
Dwivedi S, Rao G, Dey A, Mukherjee P, Wren J, Bhattacharya R
Cancers (Basel). 2021; 13(5.
PMID: 33802524
PMC: 7961667.
DOI: 10.3390/cancers13051085.
Cellular, Extracellular and Extracellular Vesicular miRNA Profiles of Pre-Ovulatory Follicles Indicate Signaling Disturbances in Polycystic Ovaries.
Rooda I, Hasan M, Roos K, Viil J, Andronowska A, Smolander O
Int J Mol Sci. 2020; 21(24).
PMID: 33333986
PMC: 7765449.
DOI: 10.3390/ijms21249550.
PODNL1 promotes cell proliferation and migration in glioma via regulating Akt/mTOR pathway.
Geng Y, Zuo P, Li X, Zhang L
J Cancer. 2020; 11(21):6234-6242.
PMID: 33033506
PMC: 7532506.
DOI: 10.7150/jca.46901.
DEAD-Box Helicase 4 (Ddx4) Stem Cells Sustain Tumor Progression in Non-Serous Ovarian Cancers.
DOronzo S, Silvestris E, Lovero D, Cafforio P, Duda L, Cormio G
Int J Mol Sci. 2020; 21(17).
PMID: 32847044
PMC: 7503840.
DOI: 10.3390/ijms21176096.
Identification of the key genes associated with chemotherapy sensitivity in ovarian cancer patients.
Zheng H, Zhang M, Ma S, Yang W, Xie S, Wang Y
Cancer Med. 2020; 9(14):5200-5209.
PMID: 32441484
PMC: 7367617.
DOI: 10.1002/cam4.3122.
microRNA-1908-5p inhibits proliferation and promotes apoptosis by targeting PP5 in NSCLC.
Li Y, Gan L, Li W, Qin S, Liu G
Int J Clin Exp Pathol. 2020; 12(6):2139-2147.
PMID: 31934036
PMC: 6949625.
A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
Yang G, Zhang Y, Yang J
Front Oncol. 2019; 9:1207.
PMID: 31799184
PMC: 6863365.
DOI: 10.3389/fonc.2019.01207.
Comprehensive Analysis of Expression and Prognostic Value of Sirtuins in Ovarian Cancer.
Sun X, Wang S, Li Q
Front Genet. 2019; 10:879.
PMID: 31572453
PMC: 6754078.
DOI: 10.3389/fgene.2019.00879.
Identification of six serum antigens and autoantibodies for the detection of early stage epithelial ovarian carcinoma by bioinformatics analysis and liquid chip analysis.
Zou Y, Li L
Oncol Lett. 2018; 16(3):3231-3240.
PMID: 30127919
PMC: 6096275.
DOI: 10.3892/ol.2018.9027.